ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Short Interest Down 82.5% in May

ALPS Group Inc Ordinary Share (NASDAQ:ALPSGet Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totaling 5,804 shares, a decrease of 82.5% from the April 30th total of 33,182 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 29,325 shares, the short-interest ratio is presently 0.2 days.

ALPS Group Inc Ordinary Share Trading Down 1.3%

Shares of ALPS stock traded down $0.01 on Friday, hitting $0.76. 16,479 shares of the stock traded hands, compared to its average volume of 28,733. The firm has a market cap of $126.45 million, a P/E ratio of 2.30 and a beta of -0.12. ALPS Group Inc Ordinary Share has a 1-year low of $0.56 and a 1-year high of $15.00.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings initiated coverage on ALPS Group Inc Ordinary Share in a research report on Wednesday, April 8th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, ALPS Group Inc Ordinary Share has a consensus rating of “Sell”.

View Our Latest Report on ALPS

About ALPS Group Inc Ordinary Share

(Get Free Report)

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.

Further Reading

Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.